Products

We are dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs

Process and Manufacture

We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities

Explore further

Company News

Bio-Thera Solutions Announces Initiation of Phase IB / IIA Cl

Guangzhou, China -- Bio-Thera Solutions (688177:SH), acommercial-stage biopharmaceutical company developing a pipeline of innovativetherapies and biosimilars, today announced that dosinghas begun in Ph...

Bio-Thera Solutions Partners with Macter International to Mar

GUANGZHOU, China --- Bio-Thera Solutions (688177:SH), acommercial-stage biopharmaceutical company developing a pipeline of innovativetherapies and biosimilars, today announced the company has reached a...

FDA Approves Bio-Thera Solutions’ Avzivi® (bevacizumab-tnj

· Avzivi ® (BAT1706) is Bio-Thera Solution’ second FDAapproved product in the United States · Avzivi ® is the second biosimilar researched,developed, and manufactured by a Chinese pharmaceutical ...